№ lp_1_23277
File format: docx
Character count: 6410
File size: 34 KB
This document is a template for recording adverse events in clinical research studies, specifically for use in the documentation of individual events and their details.
Year:
2026
Region / City:
Boston, MA
Topic:
Clinical Research, Adverse Event Reporting
Document Type:
Form
Author:
BU Medical Campus
Target Audience:
Clinical research staff
Period of validity:
Ongoing
Approval Date:
2026-01-01
Date of Changes:
Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2019
Region / city:
OECD
Topic:
Adverse Outcome Pathway, oxidative stress, brain development, neurotoxicity
Document Type:
External Review Report
Author:
OECD EAGMST review manager
Target Audience:
Scientific community, regulators, policymakers
Period of validity:
Not specified
Approval Date:
June 2018
Date of revisions:
17 March 2020
Year:
2024
Region / city:
UK
Topic:
Climate change, extreme weather, workplace safety
Document type:
Policy document
Organization / institution:
UNISON, TUC
Author:
UNISON
Target audience:
Trade union representatives, employers, workers
Period of validity:
2024–2025
Approval date:
Not specified
Date of changes:
Not specified
Note:
Year
Year:
2003
Region / City:
Mount Sinai Hospital
Subject:
Clinical Research
Document Type:
Guideline
Organization / Institution:
Mount Sinai Hospital REB
Author:
REB Chair
Target Audience:
Clinical Investigators, Research Staff
Effective Period:
Ongoing
Approval Date:
November 6, 2003
Revision Date:
July 8, 2015
Year:
2019
Region / City:
International
Subject:
Medical device adverse event reporting
Document Type:
Proposed document
Organ / Institution:
International Medical Device Regulators Forum (IMDRF)
Author:
IMDRF Adverse Event Terminology Working Group
Intended Audience:
Regulatory authorities, healthcare providers, manufacturers, reporters of adverse events
Period of validity:
Not specified
Approval date:
27th June 2019
Date of Changes:
Not specified
Year:
Not specified
Region / City:
Not specified
Topic:
Adverse events tracking in clinical studies
Document Type:
Template
Organization / Institution:
Not specified
Author:
Not specified
Target Audience:
Site Monitors, Principal Investigators, study team members
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Modifications:
Not specified
Year:
2020
Region / City:
International
Topic:
Medical device regulation
Document Type:
Final Document
Organization / Institution:
International Medical Device Regulators Forum (IMDRF)
Author:
IMDRF Adverse Event Terminology Working Group
Intended Audience:
Regulatory authorities, medical device manufacturers, healthcare providers
Period of Validity:
Not specified
Approval Date:
18 March 2020
Date of Changes:
Not specified
Note:
Year
Theme:
Healthcare, Medication Safety, Adverse Drug Event Prevention
Document Type:
Program Evaluation Report
Organization / Institution:
Centers for Medicare & Medicaid Services (CMS)
Target Audience:
Healthcare Providers, Medicare Beneficiaries, Policymakers
Year:
2022
Region / City:
N/A
Topic:
Adverse Reaction Tracking, Drug Allergy Management
Document Type:
User Manual
Institution:
Department of Veterans Affairs
Author:
N/A
Target Audience:
Healthcare professionals in the Veterans Health Administration
Period of Validity:
N/A
Approval Date:
September 2022
Date of Amendments:
N/A
Year:
2025
Region / City:
United States
Subject:
Serious Adverse Event Reporting
Document Type:
Form
Organization / Institution:
National Cancer Institute (NCI)
Author:
National Cancer Institute
Target Audience:
Clinical Investigators, Medical Monitors, Research Staff
Effective Period:
Ongoing
Approval Date:
09/04/2025
Modification Date:
10/01/2024
Note:
Year
Subject:
Health Insurance Appeals
Document Type:
Notification
Target Audience:
Insurance claimants
Year:
2023/2024
Region/City:
Capital, Coast and Hutt Valley
Theme:
Healthcare, Patient Safety
Document Type:
Report
Organization/Institution:
Health New Zealand | Te Whatu Ora
Author:
Health New Zealand | Te Whatu Ora
Target Audience:
Healthcare professionals, policymakers, public health officials
Period of Validity:
1 July 2023 – 30 June 2024
Approval Date:
September 2025
Date of Changes:
Not specified
Year:
2024
Region / city:
Australia
Topic:
Adverse Childhood Experiences, Trauma, Mental Health
Document type:
Factsheet
Organization / institution:
New South Wales Department of Education
Author:
Unknown
Target audience:
Educators, Researchers, Policymakers
Period of validity:
Not specified
Date of approval:
Not specified
Date of changes:
Not specified
Note:
Year
Date:
April 18, 2025
Document type:
Public notice
Environmental review framework:
City Environmental Quality Review (CEQR) and State Environmental Quality Review Act (SEQRA)
SEQRA classification:
Type I
Project name:
Long Island City Neighborhood Plan
CEQR number:
25DCP001Q
ULURP numbers:
250175HAQ; 250176ZMQ; N250177ZRQ; 250178PCQ; 250179PPQ; 250180PPQ
Lead agency:
City Planning Commission
Proposing agency:
New York City Department of City Planning
Contact person:
Stephanie Shellooe, AICP, Director
Responsible division:
Environmental Assessment and Review Division
Project location:
Long Island City, Queens, New York
Community districts:
Queens Community District 2; Queens Community District 1
Project area size:
Approximately 54 blocks
Primary subject:
Land use actions and zoning changes
Actions covered:
Zoning map amendments, zoning text amendments, special district modifications, urban development action area designation, city map changes, disposition and acquisition of city-owned property
Public participation:
Public hearing and written comment period following hearing
Availability:
Public inspection and online access via ZAP project page
Year:
Not specified
Region / City:
Not specified
Subject:
Biological risk assessment, genetic modification, COSHH
Document type:
Guidance document
Organization:
Genetic Modification Safety Management Committee (GMSMC)
Author:
Not specified
Target audience:
Employees, Users, Tenants, visitors, Principal Investigators
Period of validity:
Not specified
Approval date:
Not specified
Amendment date:
Not specified
Year:
2026
Region / City:
Sunnybrook Hospital
Theme:
Training and Certification
Document Type:
Training Record
Organization / Institution:
Sunnybrook Hospital
Author:
HR Department
Target Audience:
New trainees in clinical positions
Period of validity:
Indefinite
Approval Date:
2026-02-02
Modification Date:
None
Year:
20XX
Region / City:
Queensland, Australia
Document Type:
Legal agreement
Organization / Institution:
Northern SEQ Distributor-Retailer Authority trading as Unitywater
Parties Involved:
Unitywater and Applicant
Subject:
Water supply and sewerage connection approvals
Relevant Legislation:
South-East Queensland Water (Distribution and Retail Restructuring) Act 2009
Obligations:
Completion of network works, maintenance during defects liability period
Effective Date:
Commencement Date of Agreement
Security:
Completion Security and Maintenance Bonds
Location:
Land described as PRD, Parish of Parish, Street Address, Queensland
Note:
Year
Organization / institution:
California State University, Fresno
Target audience:
Graduate students